Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Arcticzymes Technologies ASA

B4V
Current price
1.41 EUR +0.098 EUR (+7.47%)
Last closed 16 NOK
ISIN NO0010014632
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 874 491 727 NOK
Yield for 12 month -35.85 %
1Y
3Y
5Y
10Y
15Y
B4V
21.11.2021 - 28.11.2021

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; double-strand specific DNases and derived kits for the removal of double stranded DNA; DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids. It serves the molecular tools research and diagnostics, and biomanufacturing markets. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway. Address: SIVA Innovation Centre, Tromsø, Norway, 9294

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

327.51 NOK

P/E ratio

59.8571

Dividend Yield

Current Year

+121 514 526 NOK

Last Year

+139 937 001 NOK

Current Quarter

+27 076 901 NOK

Last Quarter

+30 662 913 NOK

Current Year

+115 460 207 NOK

Last Year

+134 644 833 NOK

Current Quarter

+24 956 973 NOK

Last Quarter

+29 310 234 NOK

Key Figures B4V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 10 281 927 NOK
Operating Margin TTM 4.08 %
PE Ratio 59.8571
Return On Assets TTM 1.49 %
PEG Ratio
Return On Equity TTM 4.75 %
Wall Street Target Price 327.51 NOK
Revenue TTM 120 351 887 NOK
Book Value 6.38 NOK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -2.4 %
Dividend Yield
Gross Profit TTM 135 352 836 NOK
Earnings per share 0.29 NOK
Diluted Eps TTM 0.29 NOK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -54.5 %
Profit Margin 12.41 %

Dividend Analytics B4V

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History B4V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation B4V

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 59.8571
Forward PE 38.0228
Enterprise Value Revenue 5.3821
Price Sales TTM 7.2661
Enterprise Value EBITDA 26.5208
Price Book MRQ 2.6964

Financials B4V

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators B4V

For 52 weeks

15.77 NOK 44.14 NOK
50 Day MA 20.01 NOK
Shares Short Prior Month
200 Day MA 27.11 NOK
Short Ratio
Shares Short
Short Percent